Conversely, the S-score were correlated with gene sets that generally were associated with tumor aggressiveness, including the EMT, cell cycle, hypoxia, angiogenesis, and TP53 signaling; this finding was consistent with the association of TP53 mutations with S-comp. The gene discussed is TP53; the disease is neoplasm.